Colorectal Cancer Clinical Trials in Phoenix, AZ

Colorectal Cancer Clinical Trials in Phoenix, AZ

View the best 10 colorectal cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Colorectal Cancer clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for colorectal cancer in Phoenix, Arizona

Image of Saint Joseph Heritage Medical Group in Santa Rosa, United States.

Tucatinib +5 More

Small Molecule Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing to see if tucatinib in combination with other drugs is more effective than standard of care drugs at treating participants with HER2 positive colorectal cancer.
Image of Alaska Oncology in Anchorage, United States.

LBL-007 +3 More

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of Banner MD Anderson Cancer Center in Phoenix, United States.

T3011 +1 More

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, T3011, to see if it's safe and effective in treating people with advanced solid tumors. The study will also compare T3011 given alone to T3011 given with another drug, pembrolizumab.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Leucovorin Calcium, Fluorouracil, Oxaliplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing the side effects of two immunotherapies, durvalumab and tremelimumab, in combination with high or low-dose radiation therapy, in treating patients with metastatic colorectal or non-small cell lung cancer.
Image of Honor Health Institute in Scottsdale, United States.

ATP128 +2 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is assessing the safety and tolerability of the ATP128 vaccine when given alone or in combination with BI 754091. The trial will also assess the efficacy of the combination of ATP128 and VSV-GP128 when given in combination with BI 754091 in patients with microsatellite stable colorectal cancer.
Image of Mayo Clinic in Arizona in Scottsdale, United States.

Liposomal Irinotecan +3 More

Topoisomerase I inhibitor

Recruiting1 awardPhase 1 & 2
This trial is studying the side effects of a combination of drugs, liposomal irinotecan, rucaparib, fluorouracil, and leucovorin calcium, in treating patients with pancreatic, colorectal, gastroesophageal, or biliary cancer that has spread to other places in the body.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.